Foresite Capital Management V, LLC Diversified Active

CIK: 0001792206 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 12, 2022

Total Value ($000): $143,141 (100.0% shares, 0.0% debt)

Holdings (14)

— Pardes Biosciences Inc 20.2%

Value ($000) $28,860 Shares 9,400,515 Est. Cost $16.37 Unrealized —

— Theseus Pharmaceuticals, Inc. 12.9%

Value ($000) $18,444 Shares 3,335,346 Est. Cost $12.42 Unrealized —

ACRS Aclaris Therapeutics, Inc. 12.3%

Value ($000) $17,565 Shares 1,258,243 Est. Cost $19.56 Unrealized -28.3%

— Somalogic, Inc. 11.1%

Value ($000) $15,894 Shares 3,516,472 Est. Cost $12.39 Unrealized —

HIMS Hims & Hers Health, Inc. 10.5%

Value ($000) $15,039 Shares 3,319,786 Est. Cost $9.03 Unrealized -52.8%

CMPX Compass Therapeutics, Inc. 8.1%

Value ($000) $11,660 Shares 4,400,000 Est. Cost $3.29 Unrealized -34.0%

— Kinnate Biopharma Inc. 7.7%

Value ($000) $11,034 Shares 875,001 Est. Cost $39.78 Unrealized —

— Adicet Bio, Inc. 6.9%

Value ($000) $9,928 Shares 680,000 Est. Cost $17.49 Unrealized —

IVVD Adagio Therapeutics, Inc. 3.3%

Value ($000) $4,696 Shares 1,431,826 Est. Cost $34.15 Unrealized -90.8%

— Gemini Therapeutics, Inc. 2.9%

Value ($000) $4,115 Shares 2,435,125 Est. Cost $13.55 Unrealized —

QSI Quantum-Si Incorporated 1.5%

Value ($000) $2,145 Shares 924,379 Est. Cost $10.48 Unrealized -63.4%

ENTA Enanta Pharmaceuticals, Inc. 1.4%

Value ($000) $1,997 Shares 42,250 Est. Cost $65.07 Unrealized -16.6%

— 23andMe Holding Co. 0.7%

Value ($000) $1,009 Shares 406,913 Est. Cost $11.69 Unrealized —

PHVS Pharvaris N.V. 0.5%

Value ($000) $755 Shares 34,142 Est. Cost $31.46 Unrealized -40.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Pardes Biosciences Inc	9,400,515	$28,860	20.2%	$16.37	—	COM	69945Q105
—	Theseus Pharmaceuticals, Inc.	3,335,346	$18,444	12.9%	$12.42	—	COM	88369M101
ACRS	Aclaris Therapeutics, Inc.	1,258,243	$17,565	12.3%	$19.56	-28.3%	COM	00461U105
—	Somalogic, Inc.	3,516,472	$15,894	11.1%	$12.39	—	COM CL A	83444K105
HIMS	Hims & Hers Health, Inc.	3,319,786	$15,039	10.5%	$9.03	-52.8%	COM CL A	433000106
CMPX	Compass Therapeutics, Inc.	4,400,000	$11,660	8.1%	$3.29	-34.0%	COM	20454B104
—	Kinnate Biopharma Inc.	875,001	$11,034	7.7%	$39.78	—	COM	49705R105
—	Adicet Bio, Inc.	680,000	$9,928	6.9%	$17.49	—	COM	007002108
IVVD	Adagio Therapeutics, Inc.	1,431,826	$4,696	3.3%	$34.15	-90.8%	COM	00534A102
—	Gemini Therapeutics, Inc.	2,435,125	$4,115	2.9%	$13.55	—	COM	36870G105
QSI	Quantum-Si Incorporated	924,379	$2,145	1.5%	$10.48	-63.4%	COM CL A	74765K105
ENTA	Enanta Pharmaceuticals, Inc.	42,250	$1,997	1.4%	$65.07	-16.6%	COM	29251M106
—	23andMe Holding Co.	406,913	$1,009	0.7%	$11.69	—	COM CL A	90138Q108
PHVS	Pharvaris N.V.	34,142	$755	0.5%	$31.46	-40.8%	COM	N69605108